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In combination with androgens, estrogens can induce aberrant growth and malignancy of the prostate gland. Estrogen action
is mediated through two receptor subtypes: estrogen receptors a (ERa) and b (ERb). Wild-type (wt) and transgenic mice
acking a functional ERa (aERKO) or ERb (bERKO) were treated with the synthetic estrogen diethylstilbestrol (DES). DES
nduced prostatic squamous metaplasia (SQM) in wt and bERKO but not in aERKO mice, indicating an essential role for
ERa, but not ERb, in the induction of SQM of prostatic epithelium. In order to determine the respective roles of epithelial
nd stromal ERa in this response, the following tissue recombinants were constructed with prostatic epithelia (E) and
stroma (S) from wt and ERKO mice: wt-S1wt-E, aERKO-S1aERKO-E, wt-S1aERKO-E, and aERKO-S1wt-E. A metaplastic
response to DES was observed in wt-S1wt-E tissue recombinants. This response to DES involved multilayering of basal
epithelial cells, expression of cytokeratin 10, and up-regulation of the progesterone receptor. Tissue recombinants
containing aERKO-E and/or -S (aERKO-S1aERKO-E, wt-S1aERKO-E, and aERKO-S1wt-E) failed to respond to DES.
Therefore, full and uniform epithelial SQM requires ERa in the epithelium and stroma. These results provide a novel insight
into the cell–cell interactions mediating estrogen action in the prostate via ERa. © 2001 Academic Press
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1INTRODUCTION
Androgen-dependent development of the male urogenital
system occurs via stromal–epithelial interactions in which
androgens elicit epithelial development through paracrine
mechanisms mediated by androgen receptors in the stroma
(Cunha et al., 1992). While androgens play a central role in
prostatic biology, estrogens also profoundly affect growth
and differentiation of the prostate. Estrogenic effects on the
prostate are complex; they may be indirect or direct. Since
the pioneering work of Huggins and Hodges on hormonal
therapy for prostate cancer (Huggins and Hodges, 1941), it
has become evident that pharmacologic doses of estrogen
elicit androgen deprivation because exogenous estrogens
suppress pituitary gonadotrophin and thus reduce testoster- a
432ne secretion by the testes (Cook et al., 1998). This indirect
ffect of estrogen on the prostate results in “chemical
astration.”
Induction of squamous metaplasia (SQM) is a specific
esponse to estrogen by the prostate gland and has been
nduced in vivo by a variety of estrogenic substances:
stradiol-17b (Tunn et al., 1979), diethylstilbestrol (DES)
Weijman et al., 1992), and zeranol (Deschamps et al., 1987).
he effect is observed in a large number of animal species as
ell as humans, including mice, rats, dogs, beef bulls,
onkeys, sheep, and goats (Andersson and Tisell, 1982;
umuller et al., 1982; Deschamps et al., 1987; Driscoll and
aylor, 1980; Habenicht and Etreby, 1988; Kesteren et al.,
996; Pylkkanen et al., 1991; Randles, 1990; Sugimura et
l., 1988; Weijman et al., 1992). Therefore SQM is consid-
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433Estrogen Action on Prostateered to be a reliable marker or endpoint for assessing
estrogenic action on the prostate. In the rats and mice, SQM
is readily observed in the anterior prostate following estro-
gen treatment (Arai, 1970; Pylkkanen et al., 1991) and we
have previously reported estrogen binding to mouse ante-
rior prostate (Cooke et al., 1991). Therefore, the mouse
anterior prostate is an appropriate lobe to study the mecha-
nism of estrogen action on the gland.
In humans, sensitivity of the prostate to estrogen begins
during fetal development. Full-term human male fetuses
and newborn male infants usually exhibit prostatic SQM
(Andrews, 1951; Brody and Goldman, 1940), which is re-
versible and has been attributed to high levels of maternal
estrogen in the last trimester of pregnancy (Andrews, 1951).
Exposure of the human fetal prostate to DES also elicits
SQM (Driscoll and Taylor, 1980; Sugimura et al., 1988;
Yonemura et al., 1995). In the adult, SQM is commonly
associated with estrogen treatment of men with benign and
malignant prostate disease (Epstein and Murphy, 1997).
Estrogen treatment also induced SQM in aging male trans-
sexuals who had undergone orchiectomy (Kesteren et al.,
1996). Thus, despite considerable variations in the mor-
phology of the prostate gland across species ranging from
zonal anatomy in human to lobular anatomy in the rodents,
a common response to estrogen is manifest in fetal and
adult tissues: the induction of SQM.
Estrogenic effects on the prostate are elicited as a result of
the binding of the estrogen to its receptor. There are two
subtypes, ERa and the more recently described ERb (Kuiper
t al., 1996). ERa and ERb are predominantly expressed in
stroma and epithelium, respectively. However, a causal
link has not been established between estrogenic effects on
prostatic epithelium and the requirement of ERa or ERb in
either prostatic epithelium or stroma. Indeed, the respec-
tive roles of ERa and ERb in the induction of prostatic SQM
re not known and are the subject of this report. An
merging body of evidence suggests that certain effects of
strogen on target epithelial cells are mediated totally, or in
art, via ERa in stromal cells (Buchanan et al., 1998, 1999;
Cooke et al., 1997, 1998). Creation of mice with nonfunc-
tional genes encoding ERa (aERKO mice) or ERb (bERKO
mice) (Krege et al., 1998) has provided a unique means to
characterize the respective roles of ERa and ERb in the
rostate. In this study tissue recombination techniques
ere used to determine the respective roles of epithelial
ersus stromal ERa in DES induction of prostatic SQM.
METHODS
Animal Surgery and Hormone Treatment
aERKO and bERKO mice were obtained by mating the appropri-
ate heterozygote mice as previously described (Krege et al., 1998;
Lubahn et al., 1993). Genotypes of pups were determined by
multiplex PCR (Krege et al., 1998; Lubahn et al., 1993), and
homozygous ERa and ERb null males were used. Athymic males
Copyright © 2001 by Academic Press. All rightere used as hosts for grafting tissue recombinants. Host males
ere treated with subcutaneous implants containing 2 mg DES and
8 mg cholesterol. These hormone pellets were made in the
aboratory with a pellet press. All animals were maintained under
ontrolled lighting and temperature conditions and housed in
ccordance with the National Institutes of Health Guidelines for
he Care and Use of Laboratory Animals. Animals were fed ad
ibitum.
Tissue Recombination
Prostates were removed from adult or neonatal (1 day old) wt or
aERKO male mice that had been killed by CO2 asphyxiation.
eparation of epithelium and stroma was performed as described
reviously (Cunha and Donjacour, 1987). Tissue recombinants
ere prepared with newborn seminal vesicle mesenchyme (SVM)
nd surgically isolated ductal tips from the anterior prostate of
dult mice. The rationale for using newborn SVM instead of
rogenital sinus mesenchyme (UGM) as a prostatic inducer was: (a)
n situ SVM is a mesenchyme that induces and supports the
ifferentiation of both seminal vesicle (SV) and anterior prostate.
uds of anterior prostate and SV grow into and branch within a
ommon mass of mesenchyme designated SVM (Cunha and Don-
acour, 1987). (b) Experimental studies showed that both SVM and
GM are nearly equivalent in their ability to induce prostatic
ifferentiation from a variety of endoderm-derived epithelia
Cunha, 1972; Cunha et al., 1980; Donjacour and Cunha, 1995;
orman et al., 1986). (c) The use of neonatal SVM versus embry-
nic UGM means that inductive mesenchyme can be obtained
rom neonatal instead of embryonic mice, thus preserving valuable
reeder females.
Tissue recombinants were prepared as described previously
Cunha and Donjacour, 1987). Briefly, SVs were removed from
ewborn wt or aERKO mice and digested with 1% trypsin (Life
Technologies, Gaithersburg, MD) in calcium- and magnesium-free
Hanks’ balanced salt solution for 60 min at 4°C. SVM was then
separated from epithelium using a von Graefe knife and fine
forceps. Anterior prostates were removed from adult male wt or
aERKO mice, and ductal tips of ;300 mm in length were excised.
Prostatic tissue recombinants were prepared by placing a prostatic
ductal tip on top of a SVM in dishes containing nutrient agar
medium as described previously (Cunha and Donjacour, 1987).
Prostatic tissue recombinants were cultured overnight on 1%
nutrient agar. The types of tissue recombinants constructed with
wt or aERKO stroma (S) and wt or aERKO epithelia (E) were
wt-S1wt-E, aERKO-S1aERKO-E, wt-S1aERKO-E, and aERKO-
1wt-E. All tissue recombinants were grafted under the renal
apsules of intact nude male mice and allowed to grow for 4 weeks
o allow prostatic development to proceed. Prostatic differentiation
as assessed in the above tissue recombinants by histology and
mmunostaining with a mouse prostate-specific antibody (Donja-
our et al., 1990). Hosts were then treated for 3 weeks by subcuta-
eous implants of pellets containing 2 mg DES plus 18 mg
holesterol or were sham treated for the same period of time.
issues were recovered from hosts and fixed in 2% paraformalde-
yde for 4 h prior to processing. The number of tissue recombinants
n each group ranged from 5 to 29.
Immunohistochemistry
A number of parameters were used to monitor the response to
estrogen. Identification of basal cells was made by immunolocal-
s of reproduction in any form reserved.
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434 Risbridger et al.ization of high-molecular-weight cytokeratin (CKH; DAKO-
cytokeratin 34bE12; Carpinteria, CA) and cytokeratin 5 (CK5;
Novocastra, UK) using these specific antibodies. Keratinization of
the prostatic epithelium was detected by immunostaining for
cytokeratin 10 (CK10; DAKO). Proliferating cells were identified by
immunostaining for proliferating cell nuclear antigen (PCNA;
DAKO). Progesterone receptor (PR) was immunostained with a
specific polyclonal antibody (DAKO), and ERa was detected with
ERa mouse monoclonal IgG 1D5 purchased from DAKO (Kurita et
l., 2000a). Both of these antibodies have been previously used in
tudies by this group (Buchanan et al., 1999; Kurita et al., 2000c).
FIG. 1. The morphology of anterior prostate from control wt
a–d), aERKO (e–h), and bERKO (i–l) mice. (a, e, i) H&E staining; (b,
, j) CKH-positive basal cells; (c, g, k) CK10-negative staining; (d, h,
) PR. Only basal cells were identified in the epithelium of wt,
aERKO, and bERKO mouse anterior prostate and not CK10 or PR.
ar, 50 mm.Rb was detected with anti-human ERb chicken polyclonal anti-
Copyright © 2001 by Academic Press. All rightbody (ERb 503 IgY) as described previously (Saji et al., 2000; van
Pelt et al., 1999). Mouse prostatic secretory proteins were detected
using an antibody previously described (Donjacour et al., 1990).
Various protocols of pretreatment, with or without antigen re-
trieval, were employed. Briefly, CK10 immunoreactivity was de-
tected in dewaxed paraffin sections after inactivation of endoge-
nous peroxidase. CK5 and CKH staining was detected after
pretreatment with 0.4% trypsin at 37°C for 10 min followed by
inactivation of endogenous peroxidase. PR and PCNA were de-
tected after antigen retrieval in 0.01 M citrate buffer, pH 6.0, for 15
min at 100°C followed by a period of cooling and inactivation of
endogenous peroxidase. A common procedure for immunostaining
was then used for all tissues. Nonspecific binding was blocked
FIG. 2. Anterior prostate from wt (a–d), aERKO (e–h), and bERKO
i–l) mice. DES treatment induced SQM (a and i) with multilayer basal
ells (b and j), CK10-positive staining (c and k), and PR expression (d
nd l) in wt and bERKO, respectively. No corresponding changes wereobserved in DES-treated aERKO tissue (e–h). Bar, 50 mm.
s of reproduction in any form reserved.
and k), and PR (f and l) is shown in control (b–f) and DES-treated
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Copyright © 2001 by Academic Press. All rightusing Super Block (Pierce, Rockford, IL), and sections were then
incubated with primary antibodies for 1 h at room temperature.
After being washed, sections were incubated for 30 min with
biotinylated horse anti-mouse IgG (Vector Laboratories, Burlin-
game, CA) or biotinylated goat anti-rabbit IgG (Zymed, San Fran-
cisco, CA) followed by incubation with a Vectastain Elite ABC kit
(Vector Laboratories) for 30 min. Immunostaining was visualized
using DAB (3,39-diaminobenzidine tetrahydrochloride).
RESULTS
Examination of ducts of the anterior prostate of control
wt, aERKO, and bERKO mice revealed a simple columnar
epithelium, lined with tall columnar secretory epithelial
cells (Figs. 1a, 1e, and 1i). A discontinuous layer of basal
cells, which exhibited immunostaining for CKH, was
FIG. 4. aERKO-S1aERKO-E tissue recombinants failed to re-
spond to DES (a–f), which is evident by H&E (a) and staining for
CKH (b), CK5 (c), CK10 (d), and PCNA (e). However, PR expression
was up-regulated (f). Bar, 50 mm.
tissues (h–l). In contrast to control tissues SQM, proliferating cellsFIG. 3. The morphology of the wt-S1wt-E tissue recombinants
was examined by H&E staining after 7 weeks growth in control
host mice (a) or in mice treated with DES during the last 3 weeks
of the grafting period (g). Immunostaining for basal cell CKH and
CK5 (b and h, c and i, respectively), SQM CK10 (d and j), PCNA (eand PR were observed in DES-treated tissues. Bar, 50 mm.
s of reproduction in any form reserved.
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436 Risbridger et al.present beneath the prostatic luminal cells of control mice
(Figs. 1b, 1f, and 1j). Neither CK10 nor PR was detected by
immunocytochemistry in either luminal or basal cells of
control mice (Figs. 1c, 1g, 1k, and 1d, 1h, 1l, respectively).
After 3 weeks of treatment with DES, epithelium of the
anterior prostate of wt and bERKO mice had undergone
uniform SQM, i.e., there were layers of stratified squamous
cells throughout the epithelium (Figs. 2a and 2i). The
anterior prostatic epithelium of aERKO mice remained
nchanged and was a simple columnar epithelium (Fig. 2e).
n anterior prostates of DES-treated wt and bERKO mice
immunostaining for CKH revealed an increase in basal
cells, which formed multiple cell layers (Figs. 2b and 2j),
while in aERKO mice the discontinuous layer of basal cells
emained unchanged (Fig. 2f). The thickened metaplastic
pithelium of wt and bERKO anterior prostates was also
positive for CK10 and PR (Figs. 2c, 2d, and 2k, 2l). In
contrast, CK10 and PR were not detected by immunocyto-
chemistry in aERKO anterior prostates (Figs. 2g and 2h).
nterior prostatic epithelium of wt and bERKO mice gave
a uniform response to DES and SQM was observed through-
out the gland. In contrast, anterior prostates of DES-treated
aERKO mice maintained a simple columnar prostatic epi-
thelium and were entirely devoid of SQM, epithelial strati-
fication, and CK10 or PR expression (Figs. 2e–2h).
Since ERa is required for DES-induced SQM of the
rostate, tissue recombinants were prepared to determine
he respective roles of epithelial versus stromal ERa in the
induction of SQM. The four types of tissue recombinants
prepared as described under Methods were wt-S1wt-E,
aERKO-S1aERKO-E, wt-S1aERKO-E, and aERKO-S1wt-E.
Full growth and differentiation of the prostatic ducts occurred
after 4 weeks of grafting of tissue recombinants into athymic
male hosts and was confirmed by the expression of mouse
prostate-specific protein as previously described (Donjacour
and Cunha, 1995). Similarly, expression of mouse prostate-
specific protein was detected in the host anterior prostate
(data not shown).
H&E staining of wt-E1wt-S tissue recombinants grown
for a further 3 weeks in control male hosts showed the
continued presence of ducts lined with tall columnar secre-
tory epithelial cells (Fig. 3a), which were underlain by a
discontinuous layer of CKH-positive and CK5-positive
basal epithelial cells (Figs. 3b and 3c). PCNA-positive epi-
thelial cells were rare (Fig. 3e). Neither CK10 nor PR was
detected in the control prostatic epithelium (Figs. 3d and
3f). In contrast, following 3 weeks of DES treatment epithe-
lium of the wt-S1wt-E tissue recombinants (Fig. 3g) and the
host’s anterior prostate exhibited uniform SQM (data not
shown). In wt-S1wt-E tissue recombinants the metaplastic
epithelium was stratified squamous, five or more cell layers
thick, and expressed CKH, CK5, and CK10 (Figs. 3h, 3i, and
3j, respectively). Many of the epithelial cells of DES-treated
wt-S1wt-E recombinants expressed PCNA (Fig. 3k). PR
expression was up-regulated in the epithelial cells of DES-
treated wt-S1wt-E recombinants (Fig. 3l).In aERKO-S1aERKO-E tissue recombinants treated for 3 m
Copyright © 2001 by Academic Press. All righteeks with DES the prostatic epithelium remained simple
olumnar, resembled that of control aERKO-S1aERKO-E
issue recombinants (data not shown), and was completely
evoid of SQM (Fig. 4). Prostatic ducts were lined with
olumnar epithelial cells (Fig. 4a) underlain by a discontinu-
us layer of CKH-positive and CK5-positive basal cells in
ES-treated aERKO-S1aERKO-E tissue recombinants
Figs. 4b and 4c, respectively). PCNA-positive epithelial
ells were rare (Fig. 4e). CK10 was not detected in the
rostatic epithelium (Fig. 4d). Surprisingly, PR was detected
n many of the prostatic epithelial cells of DES-treated
aERKO-S1aERKO-E tissue recombinants (Fig. 4f). This
bservation was confirmed in both laboratories by indepen-
ent investigators.
Uniform SQM was not observed in ducts of wt-
1aERKO-E tissue recombinants, which instead were lined
y columnar secretory prostatic epithelium in both control
nd DES-treated hosts (Figs. 5a and 5g). A discontinuous
ayer of CKH-positive and CK5-positive basal cells was
resent with (Figs. 5h and 5i) or without (Figs. 5b and 5c)
ES treatment. CK10 was not detected in control or DES-
reated specimens (Figs. 5d and 5j, respectively). The inci-
ence of PCNA-positive basal prostatic epithelial cells was
ot affected by the presence or absence of DES (Figs. 5e and
k). PR was detected in the prostatic epithelial cells of
ES-treated wt-S1aERKO-E tissue recombinants (Fig. 5l)
but not in control tissue (Fig. 5f).
aERKO-S1wt-E tissue recombinants also failed to de-
velop mature SQM when treated for 3 weeks with DES.
Prostatic tissue within aERKO-S1wt-E tissue recombi-
ants consisted of ducts lined by a single layer of epithelial
ells (Fig. 6a), which contained a discontinuous layer of
asal cells positive for CKH and CK5 (Figs. 6b and 6c). CK10
as not detected (Fig. 6d) and PCNA-stained prostatic
pithelial cells were rare (Fig. 6e), but PR nuclear immuno-
taining was detected in the prostatic epithelium (Fig. 6f).
owever, in this group two of five aERKO-S1wt-E recom-
binants exhibited small focal patches of epithelial stratifi-
cation (Fig. 6g). These small foci of epithelial stratification
were estimated to involve ,10% of the epithelium and
exhibited weak staining for PCNA, CKH, CK5 (data not
shown), and CK10 and PR (Figs. 6h and 6i). Since prostatic
SQM both in situ in the hosts’s prostate and in wt-S1wt-E
tissue recombinants is characterized as a profound uniform
change in epithelial differentiation replete with strong
expression of characteristic markers, none (5/5) of the
aERKO-S1wt-E recombinants expressed SQM.
In summary, these results showed a requirement for both
stromal and epithelial ERa to achieve full response to DES
n terms of SQM (Table 1), although the up-regulation of PR
xpression did not have the same requirement and was
bserved in all recombinant tissues regardless of their
omposition. We examined the expression of ERa protein in
anterior prostatic tissue of wt mice. In epithelium of
anterior prostate, the detection of ERa was at the threshold
f sensitivity and was not convincing prior to DES treat-
ent of control mice (Fig. 7a), but after DES treatment, ERa
s of reproduction in any form reserved.
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437Estrogen Action on Prostateexpression was observed, and ERa immunoreactivity was
readily detected in distal tips of the prostatic epithelial cells
of wt mice (Fig. 7b). As reported previously stromal cell
staining for ERa was detected in proximal ducts near the
urethra where ERa is not normally expressed in epithelium
(Fig. 7c). ERa immunostaining was not detected in aERKO
mouse prostate epithelium (Fig. 7d). Epithelial ERa was
detected in aERKO-S1wt-E tissue recombinants, after DES
treatment to host mice (Fig. 7d). As expected, ERb was
etected in the prostatic epithelium of control aERKO mice
(Fig. 7e). Likewise, ERa was detected in the samples treated
for 21 days with DES (Fig. 7f). It was noted that ERb
immunostaining was recorded in prostatic epithelium of
bERKO mice and presumed to be due to the presence of a
nonfunctional ERb protein (Fig. 7h).
DISCUSSION
The mechanism of action of estrogens in male reproduc-
tive tract tissues has been advanced by the development of
mouse models in which the estrogen receptor genes, ERa or
ERb, have been rendered nonfunctional by gene targeting
Couse and Korach, 1999; Krege et al., 1998; Lubahn et al.,
1993). This study demonstrated that the prostate of the
aERKO mouse (having only ERb) failed to undergo SQM
when treated with the potent synthetic estrogen, DES. In
contrast, prostates of wt mice (having both ERa and ERb)
nd bERKO mice (having only ERa) expressed SQM when
treated with DES. Taken together these data demonstrate
an essential role for ERa in estrogen-induced SQM of the
rostate. These data, however, do not specify whether
pithelial or stromal estrogen receptors are involved in the
nduction of prostatic SQM. ERa is expressed in both
pithelial and stromal cells of the prostate although pre-
ominantly in the stroma (Lau et al., 1998; Prins and Birch,
997; Schulze and Barrack, 1987; and this study). Using
issue recombination we have demonstrated a requirement
or both epithelial and stromal ERa to induce a complete
strogenic response in the prostatic epithelium. Collec-
ively the results from this study reveal the importance of
tromal–epithelial interactions and epithelial and stromal
Ra in estrogen-induced SQM of the prostate gland.
A universal response to estrogen by the prostate gland is
he induction of epithelial SQM in several species including
ice and men (Andersson and Tisell, 1982; Aumuller et al.,
982; Deschamps et al., 1987; Driscoll and Taylor, 1980;
abenicht and Etreby, 1988; Kesteren et al., 1996; Pylk-
kanen et al., 1991; Randles, 1990; Sugimura et al., 1988;
Weijman et al., 1992). Although this study uses high doses
of DES, prostatic SQM is a physiological phenomenon in
full-term human male fetuses and newborn male infants,
which usually exhibit prostatic SQM (Andrews, 1951;
Brody and Goldman, 1940), due to high levels of maternal
estrogen in the last trimester of pregnancy (Andrews, 1951).
In adult men, SQM is a common histologic finding that is
usually associated with hormone treatment or infarction r
Copyright © 2001 by Academic Press. All right(Epstein and Murphy, 1997). In this study, the treatment of
the transgenic aERKO and bERKO mice with estrogen
howed that the induction of SQM was mediated through
Ra. The current study identified a functional response to
Ra, namely SQM, and this is consistent with localization
f ERa in prostate epithelium and stroma. This raises the
question of whether there is another specific response to
estrogen that is mediated by ERb. It is known that ERb is
localized to the epithelium, but a functional response to
estrogen via ERb has yet to be defined in the prostate. It was
oted that immunoreactivity for ERb protein was detected
in wt and bERKO mouse prostate; this indicates that the
antibody cannot discriminate between functional and non-
functional protein in the tissues and emphasizes the need to
identify a specific biological action of estrogen through
ERb.
The requirement for both stromal and epithelial ERa as
ediators of estrogen action in the prostate implies both
irect and paracrine mechanisms. ERa protein and mRNA
nd estrogen binding have been reported in prostatic stroma
f several mammalian species, including mouse (Cooke et
l., 1991; Hatier et al., 1990; Prins and Birch, 1997; Ruberg
t al., 1982; Schleicher et al., 1984; Weaker and Sheridan,
983). In prostatic epithelium ERa protein has been de-
tected in rats following neonatal estrogen treatment (Prins
and Birch, 1997); other studies failed to detect ERa mRNA
in epithelium of the rat ventral prostate or primary cultures
of human epithelial cells (Lau et al., 1998, 2000). However,
in the present study ERa protein was detected in wt stroma
and epithelium of the mouse anterior prostate but only after
administration of DES. In wt mouse the immunocyto-
chemical staining for ERa is very weak in prostatic epithe-
ium of control adult animals and shows lobular variation
ithin the prostate, lowest in the ventral prostate and
ighest in the anterior prostate (data not shown). After
reatment with DES the immunocytochemical signal for
rostatic epithelial ERa is stronger in most areas, even
though a subset of prostatic epithelial cells remain un-
stained after estrogen treatment, especially in the region of
ductal tips (unpublished observations). It is possible that
the up-regulation of ERa in the epithelium is mediated via
ERa-positive stromal cells that were detected in the peri-
rethral region of the prostate as reported earlier (Schulze
nd Barrack, 1987) and confirmed by steroid autoradiogra-
hy (Cooke et al., 1991; Schleicher et al., 1985).
Since SQM was induced by DES only in wt-S1wt-E tissue
ecombinants, the interplay between stromal and epithelial
Ra is required for induction of mature SQM by DES. After
ES treatment, wt-S1wt-E tissue recombinants showed
ultilayering of epithelium with cells that were positive
or CKH, CK5, and CK10. A substantial number of PCNA-
ositive cells were observed in the hyperplastic basal epi-
helial cells, and PR was induced by DES in the luminal cell
ayer of wt-S1wt-E tissue recombinants. DES induced a full
nd uniform response in the epithelium of wt-S1wt-E
issue recombinants only and not in any of the other tissue
ecombinants, thus demonstrating a requirement for both
s of reproduction in any form reserved.
oS
T
w
m
g
c
l) is shown in control (b–f) and DES-treated tissues (h–l). No squamous
e
a
T
r
s
o
C
c
438 Risbridger et al.
Copyright © 2001 by Academic Press. All rightepithelial and stromal ERa. DES-induced SQM was not
bserved if ERa was absent in either prostatic epithelium or
stroma (or both) as is the case in wt-S1aERKO-E, aERKO-
1wt-E, and aERKO-S1aERKO-E tissue recombinants.
issue recombinants consisting of wt-S1aERKO-E were
FIG. 6. DES-treated aERKO-S1wt-E tissue recombinants were
xamined by H&E (a and g) and immunostaining for basal cell CKH
nd CK5 (b and c), SQM CK10 (d and h), PCNA (e), and PR (f and i).
he majority of tissue recombinant grafts failed to show any
esponse to DES (a–e), although PR was up-regulated in the
ingle-layer epithelium (f). In two of five recombinants, focal areas
f stratification were detected as indicated by H&E (g), metaplastic
K10-positive cells (h), and PR up-regulation (i) compared to
ontrols (data not shown). Bar, 50 mm.
epithelium was observed in both control and DES-treated tissues.
DES-treatment up-regulated PR in the epithelium of wt-FIG. 5. The morphology of the wt-S1aERKO-E tissue recombinants
as examined by H&E staining after 7 weeks growth in control host
ice (a) or in mice treated with DES during the last 3 weeks of the
rafting period (g). Immunostaining for basal cell CKH and CK5 (b and h,
and i, respectively), SQM CK10 (d and j), PCNA (e and k), and PR (f andS1aERKO-E recombinant grafts (l). Bar, 50 mm.
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightcomposed of a single layer of epithelial cells that were not
different from sham-treated controls. Thus, while aERKO-
S1wt-E tissue recombinants express a limited spectrum of
estrogen receptors in epithelium and stroma (see discussion
above on expression of ERa and ERb in the prostate), the
specific absence of ERa in prostatic epithelium completely
liminated the development of SQM. Even though the
pithelium of wt-S1aERKO-E tissue recombinants ex-
pressed ERb (Kuiper et al., 1996, 1997), it did not respond to
ES. Likewise, in aERKO-S1wt-E tissue recombinants the
specific absence of ERa in the prostatic stroma meant that
a uniform mature prostatic SQM did not develop in re-
sponse to DES. Thus, our data show that both epithelial and
stromal ERa are required for full and uniform induction of
QM by DES.
Although the majority of aERKO-S1wt-E tissue recom-
inants failed to respond to DES, we observed that two of
ve aERKO-S1wt-E tissue recombinants showed small
isolated foci of epithelial cells that were weakly positive for
CKH, CK5, CK10, PCNA, and PR. These small foci of
reactive epithelial cells comprised considerably less that
10% of the prostatic epithelial tissue of these aERKO-
1wt-E tissue recombinants. The vast majority of prostatic
pithelium in aERKO-S1wt-E tissue recombinants was
nonresponsive to DES. We suggest that these foci in two of
five of the aERKO-S1wt-E tissue recombinants were con-
taminated with small amounts of wt-S carried over with the
microdissected wt ductal tips used to prepare the tissue
recombinants. In these regions a limited response of wt-E to
DES treatment was initiated, but impaired due to an inad-
TABLE 1
The Number of Tissue Recombinants Showing Uniform SQM
and Up-regulation of CK10 and PR Expression
SQM CK10 PR
Wt-S1wt-E 20/21 20/21 12/12
Wt-S1aERKO-E 0/20 0/20 9/9
aERKO-S1wt-E 0/5a 0/5a 3/4
aERKO-S1aERKO-S 0/11 0/11 11/11
a As discussed in the text, two of five animals showed foci of cells
hat were positive for CK10 but the epithelium was not multilay-
red and the response was not observed throughout the recombi-
ant grafted tissue. This response was not considered to be a full,
niform SQM.
detected in aERKO mice (f, inset shows negative control) and ERa
immunostaining of prostate epithelium of DES-treated bERKO
mice (g, inset shows negative control). It was also recorded that
immunostaining for ERb was detected in bERKO mouse prostate
(h, inset shows negative control). Asterisk indicates the lumen. Bar,FIG. 7. Immunolocalization of ERa in anterior prostate epithe-
lium of wt control mice (a), DES-treated wt mice (b, inset shows
negative control), proximal stroma of wt DES-treated mice (c, inset
shows negative control), aERKO mice (d), and DES-treated tissue
recombinants of aERKO-S1wt-E (e, inset shows negative control).
Ra is up-regulated following DES treatment in both normal (b)
nd recombinant (e) epithelium and not detected in aERKO mouse50 mm.
s of reproduction in any form reserved.
c
w
s
e
r
e
r
w
t
v
e
n
a
s
t
a
(
r
o
t
e
e
t
s
p
A
A
440 Risbridger et al.equate stroma. Immunostaining of these aERKO-S1wt-E
tissue recombinants did not reveal ERa-positive stromal
ells in these small foci. However, given the extremely
eak ERa signal in wt prostatic stromal cells, this is not
urprising.
Overall, our studies demonstrated that both stromal and
pithelial ERa are required for a full uniform metaplastic
esponse to DES in the mouse anterior prostate. The pres-
nce of ERa in both the epithelium and the stroma is also
equired for estrogen-induced vaginal cornification in
hich the full cornification response occurred only in
issue recombinants having ERa in both epithelium and
stroma (Buchanan et al., 1998). Thus, our findings in the
prostate on DES-induced SQM corroborate earlier studies
indicating that full estrogenic response requires both indi-
rect paracrine mechanisms mediated by stromal ERa as
well as direct estrogen action on the epithelium mediated
by epithelial ERa. Tissue recombinant studies with steroid
receptor null mutants have recently demonstrated that in
ivo regulation of epithelial proliferation by androgen,
strogen, and progesterone is mediated by paracrine mecha-
isms in male and female hormone target organs (Cooke et
l., 1997; Kurita et al., 1998; Sugimura et al., 1986). Using
imilar techniques, the regulation of functional differentia-
ion of epithelia of male and female genital tracts requires
ppropriate steroid receptors in both epithelium and stroma
Buchanan et al., 1998, 1999; Cunha and Young, 1991).
The up-regulation of PR is a common marker of estrogen
esponse in female reproductive tissues, and up-regulation
f PR expression following estrogenic stimulation occurs in
he human and rodent prostate (Kesteren et al., 1996; West
t al., 1988). The results of this study showed that PR
xpression was detected in the luminal cell layer of all
issue recombinants, whether or not epithelial ERa was
detected. This raises the possibility that PR is regulated in
prostatic epithelium by ERb. Up-regulation of PR in endo-
metrial stroma is mediated through at least three mecha-
nisms: classical estrogen signaling through ERa, estrogen
ignaling through ERb, and mechanical stimulation plus
progesterone (estrogen is not required) (Kurita et al., 2000b).
Other as yet undiscovered mechanisms of PR regulation
may also exist. Further studies using recombinants of wt
and bERKO mouse tissue could reveal the requirement for
ERb in mediating this response, but it is essential that a
functional role for estrogens, mediated by ERb, is identified.
It is also essential that a role for progesterone in the prostate
gland is determined. Together, this information could pro-
vide justification for further studies on the mechanism of
action of estrogen via ERb and of progesterone in the
rostate.
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